The most frequent Y-autosome translocations involve an acrocentric autosome and they are frequently familial with neither phenotypic nor reproductive repercussion. However, different Y-autosome translocations have been related to infertility, due to abnormal pairing of the X and Y chromosomes at meiosis and an abnormal XY-body formation or by the disruption of the AZFs (Azoospermic Factor). Rare forms of Y-autosome translocations are those resulting in an unbalanced 45-chromosome karyotype that includes a dicentric Y+autosome chromosome. We describe a new case of a familial pseudodicentric 22;Y that is carried by 19 male members of a large family without phenotypic repercussion. Cytogenetic analysis, fluorescence in situ hybridisation (FISH) and subtelomeric Multiplex Ligation-dependent Probe Amplification (MLPA) assay have been performed. All male members of the family showed the karyotype 45,X,psu dic(22;Y)(p11.2;qter).ish psu dic(22;Y) (SRY+,DYZ3+,D14/D22Z1+). In conclusion, the presence of the dicentric chromosome in the male members of the family reported does not seem to interfere with the correct progression of spermatogenesis.

1.
Alves C, Carvalho F, Cremades N, Sousa M, Barros A: Unique (Y;13) translocation in a male with oligozoospermia: cytogenetic and molecular studies. Eur J Hum Genet 10:467–474 (2002).
2.
Andersson M, Page DC, Pettay D, Subrt I, Turleau C, et al: Y;autosome translocations and mosaicism in the aetiology of 45,X maleness: assignment of fertility factor to distal Yq11. Hum Genet 79:2–7 (1988).
3.
Brisset S, Izard V, Misrahi M, Aboura A, Madoux S, et al: Cytogenetic, molecular and testicular tissue studies in an infertile 45,X male carrying an unbalanced (Y;22) translocation: case report. Hum Reprod 20:2168–2172 (2005).
4.
Buonadonna AL, Cariola F, Caroppo E, Di Carlo A, Fiorente P, et al: Molecular and cytogenetic characterization of an azoospermic male with a de-novo Y;14 translocation and alternate centromere inactivation. Hum Reprod 17:564–569 (2002).
5.
Callen DF, Sutherland GR, Carter RF: A fertile man with tdic(Y;22): how a stable neo-X1X2Y sex-determining mechanism could evolve in man. Am J Med Genet 3:151–155 (1987).
6.
Delobel B, Djlelati R, Gabriel-Robez O, Croquette MF, Rousseaux-Prevost R, et al: Y-autosome translocation and infertility: usefulness of molecular, cytogenetic and meiotic studies. Hum Genet 102:98–102 (1998).
7.
Gardner RJ, Sutherland GR: Chromosome Abnormalities and Genetic Counseling, 3rd edition, pp 264–293 (Oxford University Press, New York 2004).
8.
Hsu LY: Phenotype/karyotype correlations of Y chromosome aneuploidy with emphasis on structural aberrations in postnatally diagnosed cases. Am J Med Genet 53:108–140 (1994).
9.
ISCN (2005): An International System for Human Cytogenetic Nomenclature, Shaffer LG, Tommerup N (eds); S. Karger, Basel 2005.
10.
Kühl H, Rottger S, Heilbronner H, Enders H, Schempp W: Loss of the Y chromosomal PAR2-region in four familial cases of satellited Y chromosomes (Yqs). Chromosome Res 9:215–222 (2001).
11.
Siffroi JP, Benzacken B, Angelopoulou R, Le Bourhis C, Berthaut I, et al: Alternative centromeric inactivation in a pseudodicentric t(Y;13)(q12; p11.2) translocation chromosome associated with extreme oligozoospermia. J Med Genet 38:802–806 (2001).
12.
Smith A, Fraser IS, Elliott G: An infertile male with balanced Y;19 translocation. Review of Y;autosome translocations. Ann Genet 22:189–194 (1979).
13.
Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, et al: Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet 5:933–943 (1996).
14.
White LM, Treat K, Leff A, Styers D, Mitchell M, Knoll JH: Exclusion of uniparental inheritance of chromosome 15 in a fetus with a familial dicentric (Y;15) translocation. Prenat Diagn 18:111–116 (1998).
15.
Wimmer R, Schempp W, Gopinath PM, Nagarajappa CS, Chandra N, et al: A family case of fertile human 45,X,psu dic(15;Y) males. Cytogenet Genome Res 115:94–98 (2006).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.